The Government has provided an update on the ongoing supply challenges affecting certain epilepsy medications. In response to a query by Labour MP Tanmanjeet Singh Dhesi in Parliament, the Department for Health and Social Care evaluated the sufficiency of epilepsy medication supplies. Reports have highlighted shortages of medicines, including those for epilepsy, over recent years.
Health minister Zubir Ahmed stated that the department is collaborating closely with the industry to address intermittent supply issues with some epilepsy drugs. Through concerted efforts and by urging manufacturers to expedite deliveries, most supply problems have been resolved. Nevertheless, a few individuals are still encountering difficulties in obtaining two specific medications.
Mr. Ahmed disclosed that there is a supply problem with topiramate and phenobarbital tablets from certain manufacturers, crucial for managing epilepsy. While resupply from affected manufacturers is pending confirmation, alternative manufacturers have adequate stock to meet patient requirements. The National Health Service has distributed management guidance in response to these developments.
According to information on the NHS website, topiramate is prescribed for epilepsy and migraine treatment. It functions by reducing abnormal brain electrical activity, thereby restoring nerve activity balance. This medication requires a prescription and is typically taken twice daily in tablet, capsule, or liquid form. For epilepsy treatment, it may take two to four weeks for noticeable effects.
Phenobarbital, also known as phenobarbitone, is utilized to lessen the severity and frequency of epileptic seizures, available in tablet or liquid form.
Stay informed with Daily Mirror as your ‘Preferred Source’ on Google News for timely access to news that matters to you.